These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21955364)

  • 1. Quantifying cannabis use with the timeline followback approach: a psychometric evaluation.
    Norberg MM; Mackenzie J; Copeland J
    Drug Alcohol Depend; 2012 Mar; 121(3):247-52. PubMed ID: 21955364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use.
    Robinson SM; Sobell LC; Sobell MB; Leo GI
    Psychol Addict Behav; 2014 Mar; 28(1):154-62. PubMed ID: 23276315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cannabis Problems Questionnaire: factor structure, reliability, and validity.
    Copeland J; Gilmour S; Gates P; Swift W
    Drug Alcohol Depend; 2005 Dec; 80(3):313-9. PubMed ID: 15916867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off.
    Martin G; Copeland J; Gates P; Gilmour S
    Drug Alcohol Depend; 2006 Jun; 83(1):90-3. PubMed ID: 16310973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults.
    Bashford J; Flett R; Copeland J
    Addiction; 2010 Apr; 105(4):615-25. PubMed ID: 20403014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU).
    Cuttler C; Spradlin A
    PLoS One; 2017; 12(5):e0178194. PubMed ID: 28552942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the CAST and SDS scales in young adult cannabis users.
    Cuenca-Royo AM; Sánchez-Niubó A; Forero CG; Torrens M; Suelves JM; Domingo-Salvany A
    Addict Behav; 2012 Jun; 37(6):709-15. PubMed ID: 22386300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial.
    Tomko RL; Baker NL; McClure EA; Sonne SC; McRae-Clark AL; Sherman BJ; Gray KM
    Drug Alcohol Depend; 2018 Jan; 182():1-7. PubMed ID: 29112827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral assessment of gambling: an application of the timeline followback method.
    Weinstock J; Whelan JP; Meyers AW
    Psychol Assess; 2004 Mar; 16(1):72-80. PubMed ID: 15023094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Adolescent Cannabis Problems Questionnaire (CPQ-A): psychometric properties.
    Martin G; Copeland J; Gilmour S; Gates P; Swift W
    Addict Behav; 2006 Dec; 31(12):2238-48. PubMed ID: 16626880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
    Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment.
    Connor JP; Gullo MJ; Feeney GF; Young RM
    Drug Alcohol Depend; 2011 Jun; 115(3):167-74. PubMed ID: 21163593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users.
    Martin G; Copeland J; Swift W
    J Subst Abuse Treat; 2005 Oct; 29(3):207-13. PubMed ID: 16183469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis.
    Hides L; Dawe S; Young RM; Kavanagh DJ
    Addiction; 2007 Jan; 102(1):35-40. PubMed ID: 17207121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis-related deficits in real-world memory.
    Montgomery C; Seddon AL; Fisk JE; Murphy PN; Jansari A
    Hum Psychopharmacol; 2012 Mar; 27(2):217-25. PubMed ID: 22389086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a short cannabis problems questionnaire for adolescents in the community.
    Proudfoot H; Vogl L; Swift W; Martin G; Copeland J
    Addict Behav; 2010 Jul; 35(7):734-7. PubMed ID: 20356683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the Treatment Outcomes Profile.
    Marsden J; Farrell M; Bradbury C; Dale-Perera A; Eastwood B; Roxburgh M; Taylor S
    Addiction; 2008 Sep; 103(9):1450-60. PubMed ID: 18783500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimethod alexithymia assessment in adolescents and young adults with a cannabis use disorder.
    Dorard G; Berthoz S; Haviland MG; Phan O; Corcos M; Bungener C
    Compr Psychiatry; 2008; 49(6):585-92. PubMed ID: 18970907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial.
    Hjorthøj CR; Fohlmann A; Larsen AM; Arendt M; Nordentoft M
    Addiction; 2012 Jun; 107(6):1123-31. PubMed ID: 22151583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.